Patents Assigned to Kai Pharmaceuticals
  • TRANSDERMAL DELIVERY OF PKC MODULATORY PEPTIDES THROUGH MICROPORATED SKIN
    Publication number: 20100311671
    Abstract: Disclosed herein are methods for transdermal delivery of PKC modulatory peptides. Generally, methods comprise the delivery of an isozyme specific PKC peptide modulator through skin that has been microporated, e.g., with an array of microneedles. Such methods may be used to administer therapeutically effective amounts of an isozyme selective PKC peptide inhibitor or activator.
    Type: Application
    Filed: March 25, 2010
    Publication date: December 9, 2010
    Applicant: Kai Pharmaceuticals
    Inventors: Randolph Mellus Johnson, Felix Karim, Lisa Christine Ryner